← FDA DRUG APPROVALS

FDA ANDA · ANDA074737

CAPTOPRIL

Sponsor: COREPHARMA

APPLICATION
ANDA074737
TYPE
ANDA
ORIGINAL APPROVAL
1998-10-28
LATEST ACTION
2024-07-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

CAPTOPRILPrescription
CAPTOPRIL 25MG · TABLET · ORAL
CAPTOPRILPrescription
CAPTOPRIL 50MG · TABLET · ORAL
CAPTOPRILPrescription
CAPTOPRIL 12.5MG · TABLET · ORAL
CAPTOPRILPrescription
CAPTOPRIL 100MG · TABLET · ORAL

Approval history

2024-07-08Labeling · Supplement 13 · standardAP
2020-03-03Labeling · Supplement 11 · standardAP
2016-02-16Labeling · Supplement 9 · standardAP
2016-02-16Labeling · Supplement 10 · standardAP
2015-01-20Labeling · Supplement 8 · standardAP
2011-04-08Labeling · Supplement 7AP
2007-11-13Labeling · Supplement 5AP
1998-10-28OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →